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OBJECTIVE: Many changes in mucosal morphology are observed following ileal pouch construction, including colonic
metaplasia and dysplasia. Additionally, one rare but potential complication is the development of adenocarcinoma of
the reservoir. The aim of this study was to evaluate the most frequently observed histopathological changes in ileal
pouches and to correlate these changes with potential risk factors for complications.
METHODS: A total of 41 patients were enrolled in the study and divided into the following three groups: a non-
pouchitis group (group 1) (n = 20; 8 males; mean age: 47.5 years) demonstrating optimal outcome; a pouchitis
without antibiotics group (group 2) (n= 14; 4 males; mean age: 47 years), containing individuals with pouchitis who
did not receive treatment with antibiotics; and a pouchitis plus antibiotics group (group 3) (n= 7; 3 males; mean age:
41 years), containing those patients with pouchitis who were administered antibiotics. Ileal pouch endoscopy was
performed, and tissue biopsy samples were collected for histopathological analysis.
RESULTS: Colonic metaplasia was found in 15 (36.6%) of the 41 patients evaluated; of these, five (25%) were from
group 1, eight (57.1%) were from group 2, and two (28.6%) were from group 3. However, no correlation was
established between the presence of metaplasia and pouchitis (p= 0.17). and no differences in mucosal atrophy or
the degree of chronic or acute inflammation were observed between groups 1, 2, and 3 (p.0.45). Moreover, no
dysplasia or neoplastic changes were detected. However, the degree of mucosal atrophy correlated well with the
time of postoperative follow-up (p= 0.05).
CONCLUSIONS: The degree of mucosal atrophy, the presence of colonic metaplasia, and the degree of acute or
chronic inflammation do not appear to constitute risk factors for the development of pouchitis. Moreover, we
observed that longer postoperative follow-up times were associated with greater degrees of mucosal atrophy.
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INTRODUCTION
Restorative proctocolectomy with ileal pouch-anal ana-
stomosis (IPAA) has become the gold standard procedure
for the treatment of familial adenomatous polyposis (FAP),
as well as ulcerative colitis (UC) that is refractory to clinical
treatment. This procedure reduces the inconvenience of the
diarrhea associated with direct ileoanal anastomosis while
preserving sphincter function. In the case of the UC, this
technique has become the most widely used elective
surgical procedure (1).
However, IPAA is not free of complications; nonspecific
inflammation of the ileal pouch, or pouchitis, is the most
common long-term complication, with an incidence ranging
from 14 to 59% (2-12).
Although the physiopathology of pouchitis remains
controversial, there is strong evidence that this condition
represents a reactivation of UC. In particular, pouchitis occurs
almost exclusively in patients who underwent IPAA for UC,
rather than for FAP (7,12,13), which suggests an autoimmune
etiology for this condition in genetically predisposed indi-
viduals. Other factors in support of this theory include the
existence of extra-intestinal events associated with an in-
creased risk of developing pouchitis (3,9,14) and the endo-
scopic and histopathological similarities observed between
patients with pouchitis and those with UC (15,16).
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There is also an increased risk for the development of
pouchitis in female patients (6) and in those with extensive or
severe UC (7), extra-intestinal manifestations (3,9,14), early
disease onset (3), the use of non-steroidal anti-inflammatory
drugs (10), gene polymorphisms in the interleukin-1 receptor
and TNF-1 antagonists (11) and the presence of perinuclear
anti-neutrophil cytoplasmic antibodies (pANCA) (17). Addi-
tionally, colonic metaplasia is a common histopathological
finding for the ileal pouch and is observed in approximately
50% of patients with pouchitis and approximately 18% of
patients undergoing IPAA without pouchitis (18).
In addition, it was observed that the occurrence of
pouchitis, particularly in its chronic course, appears to
increase the risk of the development of adenocarcinoma of
the ileal pouch according to the sequence of atrophy-
dysplasia-carcinoma (19-21). Furthermore, it was found that
up to 71% of ileal pouches with severe atrophy develop
dysplasia, which is in contrast to cases of discrete atrophy
that generally do not develop dysplastic changes (22).
This study sought to characterize the most frequent
histopathological changes of ileal pouches and to correlate
these changes with potential risk factors for the develop-
ment of pouchitis.
PATIENTS AND METHODS
Patients
This study included 41 patients who underwent IPAA for
UC between 1985 and 2006 at the Hospital of the Faculty of
Medicine at the University of Sa˜o Paulo (HC-FMUSP) in the
Division of Colon and Rectal Surgery. The ileal J-pouch
technique was used according to the description provided
by Utsunomiya et al. (23).
A total of 15 men and 26 women with a mean age of 46.2
(range: 23 to 66) years were included in the study. The mean
time-course of the disease was 190 (range: 15 to 312) months,
and the mean duration of the postoperative follow-up period
was 141.7 (range: 24 to 276) months. A total of 33 patients
retained a temporary ileostomy for an average period of 22.3
(range: 1 to 168) months, whereas eight patients underwent a
single surgery with primary anastomosis.
The pouchitis disease activity index (PDAI), which was
previously used by Sandborn et al. (24), was adopted to
define the presence or absence of pouchitis in patients based
on clinical, endoscopic, and histopathological criteria.
Thus, the patients were divided into the following three
groups: the non-pouchitis group (NP), containing indivi-
duals without pouchitis at the time of evaluation (n = 20);
the pouchitis/no antibiotics group (PNA), containing indi-
viduals with pouchitis who were not administered anti-
biotics (n = 14); and the pouchitis plus antibiotics group
(PA), including patients who had pouchitis and were
administered antibiotics (n = 7).
The research project was approved by the CAPPESQ
(Commission for Ethics Review of Research Projects) of the
HCFMUSP under protocol number 1162/07. All included
patients signed an informed consent form prior to
participation.
METHODS
Endoscopic evaluation of the ileal pouch
All patients underwent an endoscopic evaluation of the
ileal pouch (using a sterile rigid rectoscope for children)
with no prior bowel preparation. The endoscopic assess-
ment of the ileal pouch was performed and analyzed
according to the PDAI (24).
Histopathological assessment
After the luminal contents were aspirated, two biopsies
were taken from areas of major inflammation, if present,
and care was taken to avoid suture lines and stapling. The
fragments were then sent for histopathological assessment.
Three pathologists participated in the study, and in addition
to the criteria of the PDAI previously cited (24), these
individuals described the histological patterns observed in
accordance with the following criteria: the degree of acute
inflammation, the degree of chronic inflammation, the
degree of activity, the presence of colonic metaplasia,
the degree of atrophy of the mucosa and the degree of
malignancy. These data are shown in Table 1.
Statistics analysis
An un-paired T-test was used for the histopathological
analysis of the three groups. Furthermore, the Shapiro-Wilk
normality test was applied to the NP, PNA, and PA groups
to evaluate both the duration of the disease (p= 0.661, 0.589,
and 0.442, respectively) and the postoperative follow-up
period (p= 0.389, 0.051, and 0.218, respectively). Next, an
ANOVA was performed on the same groups, which led us
to conclude that these three groups were homogeneous in
terms of both the duration of the disease (p = 0.222) and the
postoperative follow-up period (p= 0.139). Additionally,
p,0.05 was defined as the threshold of significance.
RESULTS
Histopathological evaluation of biopsies
According to the histopathological biopsy results, we
observed that longer post-operative follow-up times were
associated with a greater degree of mucosal atrophy
(p= 0.055). However, there was no correlation between this
Table 1 - Graduation and criteria adopted for the
histopathological characterization of ileal pouches.
Histopathological Change Graduation
Degree of chronic inflammation
(eosinophilic and lymphoplasmacytic)
Mild (0)
Moderate (1)
Intense (2)
Degree of acute inflammation
(polymorphonuclear granulocytes)
Absent (0)
Mild (1)
Moderate (2)
Intense (3)
Degree of activity Absent (0)
Acute cryptitis (1)
Crypt microabscesses (2)
Erosion or ulceration (3)
Presence of colonic metaplasia Absent (0)
Present (1)
Degree of mucosal atrophy Absent (0)
Distortion of crypts (1)
Atrophy of crypts (2)
Degree of malignancy (cytoarchitectural
atypia)
Mild (0)
Low grade (1)
High degree (2)
Intramucosal Carcinoma (3)
Invasive Carcinoma (4)
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histopathological change and the elapsed disease time
(p= 0.5632). These data are presented in Table 2.
The histopathological pattern observed in healthy ileal
pouches is shown below in Figure 1, whereas atrophy of the
mucosa is illustrated in Figure 2.
Colonic metaplasia was observed in 15 (36.6%) of the 41
patients evaluated; of these, five (25%) were from the NP
group, eight (57.1%) were from the PNA group, and
two (28.6%) were from the PA group. No dysplasias or
neoplastic changes were observed.
In addition, there were no statistically significant differ-
ences between the three groups with regard to the degree of
mucosal atrophy (p= 0.5203) (Figure 2); the presence of
colonic metaplasia (p= 0.1697) (Figure 3); the degree of acute
inflammation (p= 0.4434) (Figure 4); and the degree of
chronic inflammation (p= 0.9999).
There were also no significant correlations between
colonic metaplasia and elapsed disease time (p= 0.4670)
or elapsed post-operative follow-up time (p = 0.2041) and
between the degree of chronic inflammation and the degree
of mucosal atrophy (p = 0.2396), the presence of colonic
metaplasia (p= 0.8275), elapsed disease time (p= 0.2031) or
elapsed post-operative follow-up time (p = 0.4980).
DISCUSSION
Since its first description in 1978 by Parks and Nicholls
(25), the ileal pouch technique has been widely used to
achieve sphincter preservation and a reduction in the
number of bowel movements in patients undergoing total
proctocolectomy. Apart from its contraindications (acute
complicated diseases, sphincter dysfunction, malnutrition
or coexistence of cancer of the middle or distal portion of the
rectum or anus), this technique has become the most widely
used elective surgical procedure for patients with UC (1).
Prior to the introduction of the ileal pouch, patients
underwent either the permanent ileostomy of Brooke (26) or
ileoanal anastomosis and experienced a consequently high
number of daily bowel movements. The first pouch
technique, described by Parks and Nicholls, uses three folds
of small intestine that are formed into an ‘‘S’’ shape.
Subsequently, other ileal pouch techniques have been
described, such as the isoperistaltic loop technique of
Fonkalsrud and Ament (27), which uses four loops shaped
into a ‘‘W’’, that described by Lubowski and Nicholls (28),
and the ‘‘J’’ pouch described by Utsunomiya (23), which
was the technique employed in the current study.
Clinically, pouchitis is characterized by watery diarrhea,
an increased number of bowel movements, abdominal pain,
fecal urgency, incontinence, fever, malaise, and in certain
cases, intestinal bleeding. This disorder can also be accom-
panied by extra-intestinal manifestations of UC. Acute or
chronic forms can be observed, although the acute forms are
more common (29). Additionally, recurrent episodes are
reported at variable rates, ranging from 24.6 (7) to 66% (12).
We used the PDAI criteria in our study because we
believed that appropriate diagnostic tests for pouchitis should
be performed, including endoscopic examination, biopsy,
and histopathological analysis. It has previously been shown
that the diagnoses of as many as 25% of patients with the
typical symptoms of pouchitis are not confirmed endoscopi-
cally or histopathologically (8). Differential diagnoses are
Table 2 - Correlation between elapsed times of disease and post-operative follow-up with the degree of mucosal atrophy.
Degree of mucosal atrophy Elapsed time of disease Elapsed time of post-operative follow-up
Average Standard error p-value Average Standard error p-value
0 184.6154 13.28076 0.5632 126.0000 12.75617 0.0552
1 199.6875 22.04535 162.0000 12.96148
Figure 1 - Healthy ileal pouch mucosa, where villous: crypt ratio is 3 : 1. Presence of Paneth cells, ‘‘brush border’’ and less amount of
goblet cells compared to colon.
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important to rule out other inflammatory (e.g., cuffitis,
Crohn’s disease, certain infections of the pouch) and non-
inflammatory conditions (e.g., decreased complacency,
irritable pouch syndrome, stenosis, a long efferent loop,
decreased emptying, pelvic floor dysfunction or adhesions)
(10,30).
A previous study correlated the presence of colonic
metaplasia with inflammation of the ileal pouch and
suggested that villous atrophy and crypt hyperplasia
predominantly represent a reparative response to the
construction of the ileal pouch. In addition, the absence of
metaplasia in pouches constructed by FAP would suggest
that such a transformation of the mucosa is attributable to
both the basic disease, as well as to adaptive responses to
anatomical conformation (31).
However, our study did not confirm an association
between colonic metaplasia and the presence of pouchitis.
However, we did observe a correlation between mucosal
atrophy and the duration of post-operative follow-up,
regardless of the presence of pouchitis, and this finding is
contrary to that of Apel et al., which suggested that the
presence of villous atrophy does not increase with elapsed
disease time (32). Thus, additional factors besides fecal
stasis and bacterial proliferation are likely involved in the
adaptive process of the ileal pouch mucosa, as preliminary
studies have suggested (33).
Figure 2 - Mucosal atrophy, where villous: crypt ratio is 1:1. Enlargement of the villi, Lymphocytic predominance and lamina propria’s
fibroplasia.
Figure 3 - Colonic Metaplasia. Only crypts are observed. Absence of Paneth cells or villi.
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Trovato et al. (34) assessed ileal pouches using either
confocal laser endomicroscopy in vivo or conventional
histopathological analysis and found incidences of colonic
metaplasia of 67.7% and 83.3%, respectively, as well as an
incidence of villous atrophy of 83.3% using both techniques.
In our study, both colonic metaplasia and villous atrophy
were observed in 36.6% of patients, and no dysplasia was
detected in either study.
Although the neoplastic transformation process was not
the focus of our study, we considered the complete
histopathological characterization of the ileal pouch to be
relevant, including the detection of pre-neoplastic changes.
Although rare, adenocarcinoma of the reservoir has been
described and is thought to be a consequence of atrophic
chronic pouchitis. It has also been assumed that persistent
inflammation of the pouch may result in malignant
degeneration to resemble what occurs in the inflamed
colon. Additionally, there are reports of the development of
adenocarcinomas in the ileal pouch mucosa that exhibit
intense chronic inflammation and atrophy without a prior
history of neoplasms or other risk factors (19,35,36).
No dysplasia or ileal pouch neoplasia was detected in
our patients, which is consistent with the results of most
previous studies (37-41). The study by Kariv et al. (42)
evaluated 3,203 patients with ileal pouches and found
dysplasia and adenocarcinoma incidences of 0.72% and
0.36%, respectively. However, the only parameters that
these authors considered to represent risk factors for ileal
pouch neoplasia were a preoperative diagnosis of dyspla-
sias or adenocarcinomas of the colon or rectum.
The study by MKoma et al. (43) reviewed 12 studies from
retrospective case series and 15 case reports and observed the
following risk factors for the neoplastic transformation of
ileal pouches: pouchitis, preoperative dysplasia or cancer, an
interval greater than 10 years from the onset of UC, type C
mucosal changes of the pouch mucosa, extra-intestinal mani-
festations and prior treatment with the stapled anastomotic
technique. Pouch-related cancer did not occur in any of these
patients within 10 years of the diagnosis of UC.
Thus, early postoperative endoscopic surveillance is
generally not justified for these patients. However, for
pouch patients with longer postoperative times, it would be
interesting to perform routine endoscopic examinations,
even in asymptomatic patients, to pursue mucosal atrophy
due to the typical sequence of atrophic pouchitis - dysplasia
– adenocarcinoma (19-21).
The degree of mucosal atrophy, the presence of colonic
metaplasia and the degree of acute or chronic inflammation
do not appear to constitute risk factors for the development
of pouchitis. Moreover, we found that longer postoperative
follow-up times were associated with greater degrees of
mucosal atrophy.
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